To amend the Public Health Service Act to reauthorize a program under which the Secretary of Health and Human Services makes grants to State professional licensing boards for the development and implementation of policies to reduce statutory and regulatory barriers to telemedicine, and for other purposes.

HR10920, introduced by Rep. Cammack (R-FL-3) on October 29, 2026, amends the Public Health Service Act to reauthorize a grant program under which HHS provides funding to state professional licensing boards to develop and implement policies reducing statutory and regulatory barriers to telemedicine. The bill has been referred to the House Committee on Energy and Commerce. No specific funding amount is authorized in the bill text; it reauthorizes an existing program whose previous appropriations have been modest (typically under $10M annually). The mechanism is straightforward: grants incentivize states to harmonize or reduce licensing barriers, particularly for cross-state telemedicine, which has been a persistent bottleneck for virtual care adoption. For pure-play telehealth companies like Teladoc ($TDOC) and Amwell ($AMWL), reduced state-level friction directly expands the pool of patients and providers they can serve without costly multi-state licensing compliance. The bill is early-stage with no cosponsors, so passage is uncertain, but telemedicine has strong bipartisan support. No convergence with other signals is present in the provided data. The primary winners are telehealth platforms; losers are limited to state boards that may resist losing licensing authority, but no public companies are negatively impacted. The legislative path requires committee markup, House passage, Senate companion, and presidential action—likely extending into 2027 if it advances.